RTC
DGX icon

Riverview Trust Company’s Quest Diagnostics DGX Stock Holding History

Riverview Trust Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-248
Closed -$42K – 307
2025
Q1 		$42K Hold
248
– – 0.04% 247
2024
Q4 		$37.4K Hold
248
– – 0.03% 267
2024
Q3 		$38.5K Hold
248
– – 0.03% 279
2024
Q2 		$33.9K Hold
248
– – 0.03% 286
2024
Q1 		$33K Buy
+248
New +$32.2K 0.03% 313
2022
Q4 		– Sell
-158
Closed -$19K – 753
2022
Q3 		$19K Hold
158
– – 0.02% 370
2022
Q2 		$21K Hold
158
– – 0.02% 377
2022
Q1 		$22K Buy
+158
New +$22K 0.02% 451

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverview Trust Company's DGX Position: Q2 2025 in Review

Riverview Trust Company sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 248 shares — an estimated $42K sold.

Riverview Trust Company first reported a position in DGX in Q1 2022 and held it in 8 quarters. The position peaked at $42K in Q1 2025. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Riverview Trust Company reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Riverview Trust Company sold 248 Quest Diagnostics shares in Q2 2025, an estimated $42K.
  • Riverview Trust Company first reported a position in Quest Diagnostics in Q1 2022 and held it in 8 quarters.
  • Riverview Trust Company's Quest Diagnostics position peaked at $42K in Q1 2025.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Riverview Trust Company's 13F filing for Q2 2025, filed 21 Jul 2025.